Michael Lee Stallard

SEPTEMBER 16, 2015

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. Leading a global business means managing operations in some nations where meeting high ethical standards is more challenging given the prevalence of corruption in the local culture.

Ethics 150

Ethics Pharmaceuticals Globalization Commitment 150

HR Digest

NOVEMBER 10, 2021

Having joined the world’s largest pharmaceutical company, she is now out to raise the bar for human resources leadership across the organization. The HR Digest: What are the biggest challenges executives supporting pay equity for women and minorities currently face? ? .

Diversity 102

Diversity Commitment Learning-by-Doing Globalization 102

Marshall Goldsmith

FEBRUARY 8, 2018

Teaches leadership to executives and emerging leaders around the world. a holding company that operates seven distinct business. Former Chairman and Chief Executive Officer Global Debt Registry (MHR). Corporate Executives. Former Executive VP and Head of Strategy & Transformation at TMB Bank.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1 “With 5G, you get fast upload speeds, up to 100Gbsp on many public networks.

Stephenson 87

Stephenson Wireless Christensen Automotive 87

Harvard Business Review

JULY 6, 2017

Eric, 33, a high-potential vice president at a financial services firm, was elated to be selected by his supervisors to receive executive coaching. Frances, an executive in her forties, entered coaching after being passed over for a promotion that went to her more vocal, visible male colleague.

Execution 14

Execution 360-Degree Feedback Executive Coaching Sample 14

Strategy Driven

NOVEMBER 29, 2016

Without this kind of conditioning, recruiters are likely to overlook a veteran candidate when they see, for example, three years of military service instead of three years of pharmaceutical experience on their resume. Bill Sebra is Chief Operations Executive at Korn Ferry Futurestep. About the Author.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Marshall Goldsmith

NOVEMBER 4, 2013

While these advantages are easy to see from the vantage point of the CEO, they can be difficult to execute. Many leaders will be operating more like the managing director of a consulting firm. The same trend is occurring in pharmaceuticals and telecommunications. They have to learn to share people, capital, and ideas.

Short-term 107

Short-term Long-term Trends Telecommunications 107

Harvard Business Review

APRIL 7, 2015

Having managed or worked with clinical leaders in care-delivery organizations, the pharmaceutical industry, and government, I have observed three skills that are critical to the success of doctors and nurses as they make the transition to management: Operations management and execution. It would be a shame if they did.

Execution 8

Execution Skills Health Care Porter 8

Strategy Driven

JULY 13, 2011

Since the unit’s reported financial results were so good, the executives at the corporate headquarters didn’t ask many questions about the drivers of the unit’s profits – until it was too late. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Executive teams need to assess their industries’ and companies’ time horizons for the technology, because they will have a huge amount of strategic and business process planning to do before their companies adopt it.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. In addition, many top pharma customers (payers, etc.)

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. And what can we learn from it? Commercial.

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

NOVEMBER 29, 2018

In this article, I’d like to share the insights we’ve gleaned from the model’s first full year of operation, which hopefully organizations in health care and many other industries will find useful. The reporting lets executive leadership know precisely what is happening and unlocks frontline wisdom.

Health Care 11

Health Care System Metrics Report 11

Harvard Business Review

NOVEMBER 15, 2018

hospitals and health systems experienced an average 39% reduction in their operating margins from 2015 to 2017. As I speak with industry executives, a common refrain is “I’ve done all the easy stuff.” Here are some examples of what will be required to change the operating culture: Contract rationalization.

Cost 10

Cost System Management Franchising 10

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity.

Diversity 96

Diversity Innovation Biotechnology Short-term 96

Harvard Business Review

AUGUST 8, 2018

From various archival sources, including the Marquis Who’s Who and Bloomberg’s Executive Profile & Biography, we gathered information on their educational background, such as the school they attended for an MBA and their year of graduation. To test our argument, we collected data on 2,031 CEOs who ran 640 large U.S.

Influence 13

Influence Education Pharmaceuticals Finance 13

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. My senior executives and I made our values the language of leadership. This must come from the top.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

AUGUST 3, 2016

This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. Therefore, pharmaceutical mergers seem to substantially reduce innovation activities in the relevant market as a whole. That’s why antitrust authorities bear an awesome responsibility.

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

OCTOBER 6, 2016

In a Deloitte study of 7,000 organizations this year, 89% of executives rated “ strengthening the leadership pipeline ” an urgent issue. The culture at GE, for example, centers on execution, simplicity, and innovation. Investments in traditional leadership development are often misguided and a waste of money.

Leadership Pipeline 13

Leadership Pipeline Leadership After Action Review Pharmaceuticals 13

Harvard Business Review

JANUARY 15, 2017

These results should be deeply troubling for executives, since “business” writ large has been viewed relatively favorably in Western societies. For example, 82% of respondents said that the pharmaceutical industry needs greater regulation. Related Video. Lack of Information Stokes Globalization Anxiety.

Survey 12

Survey Media Globalization Policies 12

Harvard Business Review

NOVEMBER 9, 2011

The answers may not be as self-evident as many executives think. Of the 97 largest listed companies in the UK and the Eurozone in 2010, only 37 had a COO in their executive ranks. Most COOs in Europe are seasoned executives; they were 48 years old, on average, when they were appointed. What do you think?

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Life science company executives need to be thinking about what business they want to be in. They’re also sharing risk. The positions are there for the taking. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 21, 2012

Surprisingly, one was running operations in supposedly macho Iberia (Spain and Portugal), the other in China. A whopping 80% of graduating doctors are female too, turning the medical profession into a female sector not necessarily reflected in the big pharmaceutical or medical devices company that try and serve them.

Pharmaceuticals 13

Pharmaceuticals Maturity Education Objective 13

Harvard Business Review

NOVEMBER 10, 2017

Despite the amount they invest in corporate learning, organizations continue to struggle to connect these programs with the day-to-day work of strategy execution. ” But to enable strategy execution, learning departments need to reorient from what they’re trying to teach to where these things show up in the work.

Skills 11

Skills Agility Learning-by-Doing Content 11

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

AUGUST 14, 2018

First, interviews were conducted with 40 senior business executives from six leading Western digital firms (Google, Yahoo, eBay, Amazon, Groupon, and Uber) and their corresponding direct competitors in China (Baidu, Sohu, Taobao, JD.com, Meituan, and Didi). failure to fully embed operations in China. ineffective innovation strategies.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

NOVEMBER 27, 2015

” Some business schools have responded by hiring professors of practice, or industry executives without PhDs. Brower designed a faculty “externship” where she left her university office and for two months become part of global pharmaceutical company Eli Lilly’s daily operations.

Company 8

Company Education Pharmaceuticals Project 8

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. This isn’t all that surprising given the level of innovation activity in these sectors, but directors operating in similarly disrupted sectors should take note.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

JANUARY 22, 2014

The first concerns a complex transatlantic acquisition of a biotech company by a pharmaceutical company. There were major overlaps in corporate and operational management positions, but most employees would be retained. The second case involved the integration of a specialty company into a global pharmaceutical company.

Pharmaceuticals 8

Pharmaceuticals Uncertainty How To Middle Management 8

Harvard Business Review

DECEMBER 22, 2016

On December 7, Portland, Oregon, passed a law that will impose a surcharge on the local business taxes paid by corporations that operate in the city when the CEO’s compensation is 100 times or more the median earnings of the company’s employees. public corporations must file with the U.S.

CEO 8

CEO Black-Scholes Price Merton 8

Harvard Business Review

SEPTEMBER 29, 2011

Not long ago, the chief executive of a global telecommunications firm shared with me his frustration that "even in a meeting with the CEO, most institutional investors seek only granular data points to plug into their models. This blog post is part of the HBR Online Forum The CEO's Role in Fixing the System.

Long-term 12

Long-term CEO Short-term Asset Management 12

Harvard Business Review

MARCH 21, 2018

These kinds of statements speak to a leader’s choice of values, and a failure to understand the relationships between a safe work environment and operational performance. The reality is that virtually all workplace injuries are preventable, and safety management and operational excellence are intimately linked. At Cummins, Inc.,

Operations 17

Operations Chemicals CEO Metrics 17

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Operating in a Global Marketplace. Eight of the CEOs pointed to the challenges of operating in a fast-paced global marketplace. As a pharmaceutical company, we obviously were part of that whole ecosystem.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

MAY 16, 2011

A true partnership creates ways to manage these uncertainties, and does not default to executing against a predefined contract, as one would with a classic purchase order. The Sun-Netscape Alliance was formed when AOL acquired Netscape in 1998 but then sought to spin out the software operations of Netscape.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

FEBRUARY 29, 2016

For example, it increased both the number and status of safety personnel, and it strengthened safety operating procedures. We then tested the model using quantitative data about the incidence of safety-related errors in the context of pharmaceutical drugs. New executives take the helm. Employees leave the company.

Organization 8

Organization McCombs Pharmaceuticals Learning-by-Doing 8

Harvard Business Review

OCTOBER 25, 2018

Some bottom-decile firms share many of these characteristics, such as size and even investments, suggesting that size alone is not sufficient; what sets superstar firms apart is their ability to select and execute on their bold investments well. The link between superstar firms, sectors, and cities is complex.

Industry 12

Industry Company GDP Bottom-up 12